Anti-pan-AKT antibody
| Name | Anti-pan-AKT antibody |
|---|---|
| Supplier | Abcam |
| Catalog | ab8805 |
| Prices | $400.00 |
| Sizes | 200 µl |
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Applications | ICC/IF IHC-P WB ICC/IF ICC/IF IHC-F |
| Species Reactivities | Mouse, Rat, Human, Chicken |
| Antigen | Synthetic peptide: CRPHFPQFSYSASGTA conjugated to KLH, corresponding to amino acids 466-480 of Human pan-AKT (100% similar to Rat, Chicken and Mouse AKT sequences) |
| Blocking Peptide | AKT1 peptide |
| Description | Rabbit Polyclonal |
| Gene | AKT1 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
The Akt antibody (ab8805) is used at 1/80 on cultured neonatal rat cardiomyocytes that express a nuclear-targeted Akt construct. The green is Akt antibody, the red is Texas-red™ phalloidin that labels actin filaments.
A: Normal colon tissue B: Tumour tissue Akt antibody (ab8805) used at 1/1000 on formalin-fixed paraffin embedded tissue.
Anti-pan-AKT antibody (ab8805) at 1/500 dilution + Lysate prepared from human HT1080 cell line at 10 µgSecondaryHRP-conjugated donkey polyclonal to rabbit IgG at 1/5000 dilutiondeveloped using the ECL techniquePerformed under reducing conditions.
Product References
Antiangiogenic treatment diminishes renal injury and dysfunction via regulation - Antiangiogenic treatment diminishes renal injury and dysfunction via regulation
Bai X, Li X, Tian J, Zhou Z. PLoS One. 2014 Apr 23;9(4):e96117.
DNMT3L promotes quiescence in postnatal spermatogonial progenitor cells. - DNMT3L promotes quiescence in postnatal spermatogonial progenitor cells.
Liao HF, Chen WS, Chen YH, Kao TH, Tseng YT, Lee CY, Chiu YC, Lee PL, Lin QJ, Ching YH, Hata K, Cheng WT, Tsai MH, Sasaki H, Ho HN, Wu SC, Huang YH, Yen P, Lin SP. Development. 2014 Jun;141(12):2402-13.
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements. - Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements.
Chase A, Bryant C, Score J, Haferlach C, Grossmann V, Schwaab J, Hofmann WK, Reiter A, Cross NC. Haematologica. 2013 Mar;98(3):404-8.
The role of phospholipase D in modulating the MTOR signaling pathway in - The role of phospholipase D in modulating the MTOR signaling pathway in
Liu Y, Kach A, Ziegler U, Ong AC, Wallace DP, Arcaro A, Serra AL. PLoS One. 2013 Aug 23;8(8):e73173.
Estradiol in vivo induces changes in cardiomyocytes size in obese rats. - Estradiol in vivo induces changes in cardiomyocytes size in obese rats.
Obradovic M, Sudar E, Zafirovic S, Stanimirovic J, Labudovic-Borovic M, Isenovic ER. Angiology. 2015 Jan;66(1):25-35.
Impaired PI3K/Akt signal pathway and hepatocellular injury in high-fat fed rats. - Impaired PI3K/Akt signal pathway and hepatocellular injury in high-fat fed rats.
Han JW, Zhan XR, Li XY, Xia B, Wang YY, Zhang J, Li BX. World J Gastroenterol. 2010 Dec 28;16(48):6111-8.
An anti-urokinase plasminogen activator receptor antibody (ATN-658) blocks - An anti-urokinase plasminogen activator receptor antibody (ATN-658) blocks
Rabbani SA, Ateeq B, Arakelian A, Valentino ML, Shaw DE, Dauffenbach LM, Kerfoot CA, Mazar AP. Neoplasia. 2010 Oct;12(10):778-88.
Gene network analysis of bone marrow mononuclear cells reveals activation of - Gene network analysis of bone marrow mononuclear cells reveals activation of
Nakou M, Bertsias G, Stagakis I, Centola M, Tassiulas I, Hatziapostolou M, Kritikos I, Goulielmos G, Boumpas DT, Iliopoulos D. PLoS One. 2010 Oct 14;5(10):e13351.
Overexpression and activation of Akt2 protein in oral squamous cell carcinoma. - Overexpression and activation of Akt2 protein in oral squamous cell carcinoma.
Iamaroon A, Krisanaprakornkit S. Oral Oncol. 2009 Oct;45(10):e175-9.
RAN GTPase is an effector of the invasive/metastatic phenotype induced by - RAN GTPase is an effector of the invasive/metastatic phenotype induced by
Kurisetty VV, Johnston PG, Johnston N, Erwin P, Crowe P, Fernig DG, Campbell FC, Anderson IP, Rudland PS, El-Tanani MK. Oncogene. 2008 Dec 4;27(57):7139-49.